Market Overview

Why Prevail Therapeutics Is Trading Higher Today

Why Prevail Therapeutics Is Trading Higher Today

Prevail Therapeutics (NASDAQ: PRVL) shares are trading higher on Thursday after the company reported it will highlight multiple gene therapy programs for neurodegenerative diseases at the 2020 Alzheimer's Association International Conference.

Prevail Therapeutics is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Its pipeline products include PR001, PR006 and PR 004.

Prevail Therapeutics shares were trading up 6.01% at $16.37 on Thursday at the time of publication. The stock has a 52-week high of $19.96 and a 52-week low of $7.41.


Related Articles (PRVL)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at